Literature DB >> 7505255

Stimulation of antigen-specific T- and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant.

M Vajdy1, N Lycke.   

Abstract

In the present study we investigated immunological memory at the cellular level following oral immunization using cholera toxin (CT) as the mucosal adjuvant. We found that memory cells, isolated from mice orally primed with keyhole limpet haemocyanin (KLH) admixed with CT adjuvant 8 months earlier, responded by increased proliferation to antigen-challenge in vitro. In contrast, unstimulated memory cells or KLH-stimulated cells from naive mice did not respond. Memory cells were isolated from different lymphoid tissues; spleen (SP), mesenteric lymph nodes (MLN), Peyer's patches (PP) as well as the intestinal lamina propria (LP). Thus, oral immunization using CT adjuvant promoted the generation of memory cells that were present in both systemic and local intestinal lymphoid tissues. The demonstration of lymphokine production in the KLH-responsive cultures indicated the presence of antigen-specific memory T cells. Lymphokine production early in culture was dominated by interleukin-2 (IL-2), which peaked on day 2-3, followed by IL-5 and, in particular, interferon-gamma (IFN-gamma) which increased over time. Lamina propria memory cells were found to proliferate poorly to recall antigen in vitro compared to lymphocytes from SP or MLN. In contrast, very significant production of IL-5 and, in particular, IFN-gamma was demonstrable in LP cell cultures. The use of CT adjuvant also stimulated the generation of antigen-specific memory B cells following oral immunization. This was evidenced by KLH-specific antibody production in antigen-challenged memory lymphocyte cultures. The memory B cells produced IgM anti-KLH, while no detectable antigen-specific IgG or IgA was found. Unstimulated memory cells or naive cells failed to produce anti-KLH antibodies. These in vitro findings provide evidence that oral immunization using CT adjuvant stimulates both antigen-specific memory T and B cells. Furthermore, our data suggest the existence of memory B cells following oral CT adjuvant immunization which have retained the ability to produce IgM and which therefore probably have not undergone terminal isotype switch differentiation to other isotypes and thus have not deleted the mu constant heavy-chain gene. Finally, our data also suggest that memory T and B cells, either sessile in the various lymphoid tissues or recirculating, can be activated by antigen in situ in, for example, lymph nodes and spleen and, more importantly, in the intestinal LP itself.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7505255      PMCID: PMC1422185     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  29 in total

Review 1.  The mucosal immune system: from fundamental concepts to vaccine development.

Authors:  J R McGhee; J Mestecky; M T Dertzbaugh; J H Eldridge; M Hirasawa; H Kiyono
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

Review 2.  Memory and anergy: challenges to traditional models of T lymphocyte differentiation.

Authors:  M K Jenkins; R A Miller
Journal:  FASEB J       Date:  1992-04       Impact factor: 5.191

3.  Primary antigen-specific T-cell proliferative responses following presentation of soluble protein antigen by cells from the murine small intestine.

Authors:  N A Williams; A D Wilson; M Bailey; P W Bland; C R Stokes
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

4.  In vitro activation of murine antigen-specific memory B cells by a T-dependent antigen.

Authors:  E Yefenof; V M Sanders; J W Uhr; E S Vitetta
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

5.  Surface IgG-bearing cells retain the capacity to secrete IgM.

Authors:  D Lafrenz; J M Teale; N R Klinman; S Strober
Journal:  J Immunol       Date:  1986-03-15       Impact factor: 5.422

6.  The relationship between surface immunoglobulin isotype and the immune function of murine B lymphocytes. V. High affinity secondary antibody responses are transferred by both IgD-positive and IgD-negative memory B cells.

Authors:  D Lafrenz; S Strober; E Vitetta
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

7.  Antibodies of the secondary response can be expressed without switch recombination in normal mouse B cells.

Authors:  A P Perlmutter; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  Expression of lymphocyte surface IgE does not require switch recombination.

Authors:  Y Yaoita; Y Kumagai; K Okumura; T Honjo
Journal:  Nature       Date:  1982-06-24       Impact factor: 49.962

9.  The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.

Authors:  R A Seder; W E Paul; M M Davis; B Fazekas de St Groth
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

Review 10.  Bacterial enteric infections and vaccine development.

Authors:  J Holmgren; A M Svennerholm
Journal:  Gastroenterol Clin North Am       Date:  1992-06       Impact factor: 3.806

View more
  15 in total

1.  Development of a novel in vitro assay (ALS assay) for evaluation of vaccine-induced antibody secretion from circulating mucosal lymphocytes.

Authors:  H S Chang; D A Sack
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  CD8-deficient mice exhibit augmented mucosal immune responses and intact adjuvant effects to cholera toxin.

Authors:  E Hörnquist; D Grdic; T Mak; N Lycke
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

Review 3.  Regulation of intestinal IgA responses.

Authors:  Na Xiong; Shaomin Hu
Journal:  Cell Mol Life Sci       Date:  2015-04-03       Impact factor: 9.261

4.  Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera.

Authors:  Mohammad Murshid Alam; M Asrafuzzaman Riyadh; Kaniz Fatema; Mohammad Arif Rahman; Nayeema Akhtar; Tanvir Ahmed; Mohiul Islam Chowdhury; Fahima Chowdhury; Stephen B Calderwood; Jason B Harris; Edward T Ryan; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2011-02-23

5.  Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection.

Authors:  N Debard; D Buzoni-Gatel; D Bout
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

Review 6.  The regulation of gut mucosal IgA B-cell responses: recent developments.

Authors:  N Y Lycke; M Bemark
Journal:  Mucosal Immunol       Date:  2017-07-26       Impact factor: 7.313

7.  Cellular Dynamics of Memory B Cell Populations: IgM+ and IgG+ Memory B Cells Persist Indefinitely as Quiescent Cells.

Authors:  Derek D Jones; Joel R Wilmore; David Allman
Journal:  J Immunol       Date:  2015-10-05       Impact factor: 5.422

8.  Immunogenicity of bacterial carbohydrates: cholera toxin modulates the immune response against dextran B512.

Authors:  E Sverremark; C Fernandez
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

9.  Mucosal memory B cells retain the ability to produce IgM antibodies 2 years after oral immunization.

Authors:  M Vajdy; N Lycke
Journal:  Immunology       Date:  1995-11       Impact factor: 7.397

10.  Comparison of alternative buffers for use with a new live oral cholera vaccine, Peru-15, in outpatient volunteers.

Authors:  D A Sack; J Shimko; R B Sack; J G Gomes; K MacLeod; D O'Sullivan; D Spriggs
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.